KCM Investment Advisors LLC trimmed its holdings in Danaher Corporation (NYSE:DHR – Free Report) by 4.5% in the first quarter, HoldingsChannel reports. The fund owned 65,267 shares of the conglomerate’s stock after selling 3,072 shares during the period. KCM Investment Advisors LLC’s holdings in Danaher were worth $12,375,000 at the end of the most recent quarter.
A number of other institutional investors also recently made changes to their positions in the business. Bank Pictet & Cie Europe AG boosted its stake in shares of Danaher by 25.4% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 366,481 shares of the conglomerate’s stock valued at $83,895,000 after purchasing an additional 74,301 shares during the period. Northwestern Mutual Wealth Management Co. increased its stake in shares of Danaher by 303.7% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock worth $56,777,000 after buying an additional 186,584 shares during the period. SeaBridge Investment Advisors LLC purchased a new position in shares of Danaher in the fourth quarter worth $4,477,000. Legal & General Group Plc raised its holdings in Danaher by 1.0% during the 4th quarter. Legal & General Group Plc now owns 4,495,287 shares of the conglomerate’s stock valued at $1,029,061,000 after buying an additional 43,169 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. raised its holdings in Danaher by 220.2% during the 4th quarter. Robeco Institutional Asset Management B.V. now owns 674,373 shares of the conglomerate’s stock valued at $154,377,000 after buying an additional 463,764 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Danaher Stock Performance
NYSE:DHR opened at $196.57 on Tuesday. The stock has a market cap of $138.19 billion, a P/E ratio of 34.92, a price-to-earnings-growth ratio of 2.38 and a beta of 0.79. The firm’s fifty day simple moving average is $186.29 and its 200 day simple moving average is $196.48. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.
Danaher Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. Danaher’s payout ratio is currently 28.42%.
Analyst Upgrades and Downgrades
A number of brokerages have issued reports on DHR. Royal Bank Of Canada raised their price target on shares of Danaher from $200.00 to $215.00 and gave the stock an “outperform” rating in a report on Wednesday, July 22nd. Robert W. Baird lowered their price objective on shares of Danaher from $251.00 to $249.00 and set an “outperform” rating for the company in a research note on Friday, April 17th. Rothschild & Co Redburn set a $205.00 target price on shares of Danaher in a report on Friday, April 17th. Citigroup began coverage on Danaher in a research note on Tuesday, May 26th. They issued a “buy” rating and a $230.00 target price on the stock. Finally, Piper Sandler assumed coverage on Danaher in a report on Thursday, June 11th. They set a “neutral” rating and a $200.00 price target on the stock. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $228.91.
Read Our Latest Analysis on Danaher
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Stories
- Five stocks we like better than Danaher
- AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
- Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now
- Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
- Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
